TargAnox

About:

TargAnox develops drugs that help treat oncology and metabolic related inllnesses.

Website: http://targanox.com/

Top Investors: Partners Innovation Fund, Ascent Biomedical Ventures

Description:

Total Funding Amount:

$5.1M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2008-01-01

Founders:

Gordon Letts, Joseph Loscalzo, Kate Carroll

Number of Employees:

1-10

Last Funding Date:

2009-03-14

IPO Status:

Private

Industries: